Clinical Trials in Nashville

Showing 1541-1560 of 17,403 trials

A Study in Subjects With Neurogenic Orthostatic Hypotension

NCT07089043

This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).

Neurogenic Orthostatic Hypotension

CuraSen Therapeutics, Inc.12 participantsStarted Sep 2025

Farmington Hills, Michigan, United States • Eatontown, New Jersey, United States • New York, New York, United States +1 more locations

RECRUITINGPhase 3< 1 mile

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

NCT06532006

This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and chemotherapy as first-line treatment in patients with HER2-positive locally advanced/metastatic adenocarcinoma of the gastric and/or gastroesophageal junction (G/GEJ).Eligible subjects will be randomized to the two groups based on a 1:1 ratio. Enrolled subjects shall be treated with the study drug until the loss of clinical benefit, death, intolerable toxicity, withdrawal of informed consent, or other reasons specified by the protocol (whichever occurs first).

Gastroesophageal-junction CancerMonoclonal AntibodyGastric Cancer+1 more

Shanghai Henlius Biotech550 participantsStarted Nov 2024

Anaheim, California, United States • Los Alamitos, California, United States • Greeley, Colorado, United States +205 more locations

A Study in Subjects With Neurogenic Orthostatic Hypotension

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

Find Trials by Condition in Nashville

Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

SMP-3124LP in Adults With Advanced Solid Tumors

A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers

Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Triathlon All-Polyethylene Tibia Outcomes Study

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

GCC19CART for Patients With Metastatic Colorectal Cancer

A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC